Code | 9100D | ||||||||||
MA number | 18/0023/21-S | ||||||||||
Product Form: | tbl flm 196x50 mg/850 mg (blis.PVC/PE/PVDC/PE/PVC/Al-kalend.bal.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 09.02.2021 |
Validity: | 09.02.2026 |
Dokument: | VHS Sitagliptin_Metformin Krka.pdf |
Dokument: | VHS_súhrn Sitagliptin_Metformin Krka.pdf |
SPC: | SPC_Sitagliptin_Metformin Krka _filmom obalené tablety_03.2024.pdf |
PIL: | PIL_Sitagliptin_Metformin Krka _filmom obalené tablety_03.2024.pdf |
Safety feature | Yes |
Data update: | 22.06.2023 |